Search Login Register
Genetic Predisposition to Disease
(Genetic Predisposition)
Summary
Description:
A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.
Also Known As:
Genetic Predisposition; Genetic Susceptibility; Genetic Predispositions; Predisposition, Genetic; Susceptibility, Genetic Show All >>
Networked: 4737
relevant articles (42 outcomes,
631 trials/studies)
for this Disease
Key Drugs and Agents for Genetic Predisposition to Disease
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Biological Markers (Surrogate Marker)
:
6 outcomes 28 studies in 128 results
: IBA
-
Insulin (Novolin)
:
2 outcomes 18 studies in 175 results
:
FDA 2
-
Carbon Monoxide
:
2 outcomes 5 studies in 80 results
: IBA
-
Inosine Triphosphate (ITP)
:
2 outcomes 3 studies in 9 results
: IBA
-
Antigens
:
1 outcome 39 studies in 265 results
: IBA
-
HLA-DRB1 antigen (HLA DRB1)
:
1 outcome 10 studies in 70 results
: IBA
-
Genetic Markers (Genetic Marker)
:
1 outcome 9 studies in 39 results
: IBA
-
Interleukin-4 (Interleukin 4)
:
1 outcome 5 studies in 14 results
: IBA
-
gamma-Aminobutyric Acid (GABA)
:
1 outcome 4 studies in 9 results
: IBA
-
Cholesterol
:
1 outcome 3 studies in 27 results
: IBA
Show All >>
Diseases Related to Genetic Predisposition to Disease
-
Neoplasms (Cancer)
-
Hypertension (High Blood Pressure)
-
Genetic Predisposition to Disease (Genetic Predisposition)
-
Lung Neoplasms (Lung Cancer)
-
Infection
Show All >>
Key Therapies for Genetic Predisposition to Disease
Efficacy Chart >>
-
Chemoprevention
:
2 outcomes 3 studies in 14 results
-
Therapeutics
:
1 outcome 1 study in 7 results
-
Injections
:
1 outcome in 2 results
-
Donor Selection
:
1 outcome in 1 result
-
Transplantation (Transplant Recipients)
:
2 studies in 18 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.